10x Genomics acquires Proteintech Genomics to expand proteomics capabilities
10x Genomics Inc. (NASDAQ: TXG) announced the acquisition of Proteintech Genomics, a division within Proteintech Group that develops high-plex proteomic ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
